News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ruben Mesa: An amazing opportunity to work with Advocate Health
Ruben Mesa/LinkedIn
Mar 5, 2025, 07:08

Ruben Mesa: An amazing opportunity to work with Advocate Health

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:

“This is an amazing opportunity to work with myself, and the amazing team Advocate Health in developing our National Cancer Serviceline Cancer.”

advocate health cancer OncoDaily Oncology Ruben Mesa
Special Coverage
Blog
Apr 14, 2025, 06:39
POHER scholars and alums join Hackathon at developing AI-driven solutions for healthcare systems worldwide
Blog
Apr 14, 2025, 06:16
Jeff Allen, Pat Garcia-Gonzalez and Mark Lanasa discussed the role of AI in digital pathology - Friends of Cancer Research
Blog
Apr 14, 2025, 04:50
Joshua Reuss: Excellent updates on thymoma/thymic carcinoma from Chul Kim at TexasLung25
Blog
Apr 14, 2025, 04:39
Michael Duruisseaux: Phase 3 DeLLphi-304 - Tarlatamab Meets OS Endpoint in SCLC
Blog
Apr 14, 2025, 03:45
Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint
Blog
Apr 14, 2025, 01:50
Giannis Mountzios: Tarlatamab Improves Overall Survival in Advanced SCLC
Blog
Apr 14, 2025, 01:36
Sumanta K. Pal: Best Talk This Year - City of Hope GU Retreat
Blog
Apr 14, 2025, 01:08
The Faces of Cancer Care: Strengthening the Workforce, Saving Lives - UICC
Blog
Apr 13, 2025, 19:03
Tigran Byuzandyan: Delegation from the National Oncology Center of Armenia Explores Collaboration with Heidelberg University Hospital
Blog
Apr 13, 2025, 18:24
Akhil Santhosh: First-Line Adagrasib and Pembrolizumab for Metastatic NSCLC
Blog
Apr 13, 2025, 18:15
12th Annual Cholangiocarcinoma Foundation Conference Comes to a Close
Blog
Apr 13, 2025, 17:50
Noemi Reguart: First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy in SCLC